2024
DOI: 10.1021/acsmedchemlett.4c00343
|View full text |Cite
|
Sign up to set email alerts
|

Novel Compounds as NLRP3 Inhibitors for Treating Alzheimer’s Disease and Parkinson’s Disease

Ram W. Sabnis

Abstract: Provided herein are novel compounds as NLRP3 inhibitors, pharmaceutical compositions, use of such compounds in treating Alzheimer's disease and Parkinson's disease, and processes for preparing such compounds. Important Compound Classes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 6 publications
0
0
0
Order By: Relevance